Comment

Filter By:

Article Type
  • AlphaFold is a breakthrough in protein structure prediction, but limitations in its application to computation- and structure-guided drug discovery remain. As with structure prediction, public-domain data and benchmarking initiatives will be essential to advance the field of computational drug design.

    • Matthieu Schapira
    • Levon Halabelian
    • Rachel J. Harding
    Comment
  • Since its proposition in 2002, the Division of Chemical Biology in the Department of Chemical Sciences at the National Natural Science Foundation of China has implemented a range of constructive initiatives to break down traditional boundaries between chemistry and biology and to further bridge these two fields, in order to boost the development of chemical biology in China.

    • Zhiyi Yu
    • Peng R. Chen
    • Yan Zhang
    Comment
  • Protein glycation has long-been considered a toxic consequence of carbohydrate metabolism. Yet recent evidence demonstrates tight regulation for these non-enzymatic post-translational modifications, pointing to a broader role in cell biology rather than simply serving as a biomarker for toxicity.

    • Marissa N. Trujillo
    • James J. Galligan
    Comment
  • Biased signaling gives hormones, probes or drugs distinct functional outcomes via the same receptor. The Biased Signaling Atlas (https://BiasedSignalingAtlas.org) provides a community hub with data and tools to advance this paradigm, which may yield safer and more potent drugs.

    • Jimmy Caroli
    • Alibek Mamyrbekov
    • David E. Gloriam
    Comment
  • Artificial intelligence (AI) is poised to transform therapeutic science. Therapeutics Data Commons is an initiative to access and evaluate AI capability across therapeutic modalities and stages of discovery, establishing a foundation for understanding which AI methods are most suitable and why.

    • Kexin Huang
    • Tianfan Fu
    • Marinka Zitnik
    Comment
  • Ferroptosis is a regulated form of non-apoptotic cell death implicated in pathological settings. To be exploited clinically, ferroptosis requires reagents that unequivocally detect ferroptosis in human and animal tissues. Such tools may enable development of ferroptosis-based medicines for diverse diseases.

    • Kamyar Hadian
    • Brent R. Stockwell
    Comment
  • Genomics and metabolomics are widely used to explore specialized metabolite diversity. The Paired Omics Data Platform is a community initiative to systematically document links between metabolome and (meta)genome data, aiding identification of natural product biosynthetic origins and metabolite structures.

    • Michelle A. Schorn
    • Stefan Verhoeven
    • Justin J. J. van der Hooft
    CommentOpen Access
  • Plant biologists have recognized the potential in using small molecules identified from chemical libraries to provide insights into biological questions relevant to plants. However, the classical genetics mindset still predominant among plant scientists should evolve to embrace cross-disciplinary chemical genetics projects that will benefit future plant research.

    • Vivek Halder
    • Eugenia Russinova
    Comment